pharmaceutical-commercialization
(3)
The Drug Launch Has Too Many Translators
Citrus Health Group bought its way across the pharmaceutical launch journey. The clever part is not owning every specialty - it is deciding when each one enters the room.
Jeremy Gowler Is Building for the Minutes Before Medicine Arrives
After two decades commercializing vaccines and biopharmaceuticals, the Ophirex CEO is applying an operator’s eye to a stubborn logistical gap: what can happen between a snakebite and the hospital.
Sebby Borriello
Sebby Borriello is a pharmaceutical and medical-device commercialization veteran with 30-plus years of go-to-market leadership. After 25 years at Johnson & Johnson across wound management, biosurgery and aesthetics, he helped turn South Korea's SK Life Science from an R&D-only shop into a fully integrated US pharma company, leading the 2020 launch of its first FDA-approved drug, the epilepsy treatment XCOPRI. He later advised and joined Carmell Therapeutics as Chief Business Officer, and today serves as Executive Vice President and Chief Commercial Officer at MIDAS Healthcare Solutions, a New York startup tackling medication diversion and drug-waste accountability through its MidasVIEW platform and Anytime Witness video-verification technology.